Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02080260
Title A Study of Regorafenib in Advanced Pancreatic Cancer Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stuart Salmon
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Levine Cancer Institute-Albemarle Albemarle North Carolina 28001 United States Details
Levine Cancer Institute-South Tryon Charlotte North Carolina 28203 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Levine Cancer Institute - Pineville Charlotte North Carolina 28210 United States Details
Levine Cancer Institute - Southpark Charlotte North Carolina 28211 United States Details
Levine Cancer Institute - Mallard Creek Charlotte North Carolina 28262 United States Details
Levine Cancer Institute - University Charlotte North Carolina 28262 United States Details
Levine Cancer Institute - Ballantyne Charlotte North Carolina 28277 United States Details
Levine Cancer Institute - Concord Concord North Carolina 28025 United States Details
Levine Cancer Institute-Monroe Monroe North Carolina 28112 United States Details
Levine Cancer Institute - Cleveland Shelby North Carolina 28150 United States Details
Low Country Hematology Oncology Charleston South Carolina 29406 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field